Piper Jaffray Initiates Bristol-Myers Squibb With Underperform

Analysts at Piper Jaffray initiated coverage on

with a Underperform rating. The target price for Bristol-Myers Squibb is set to $60. Bristol-Myers Squibb shares have gained 37.27 percent over the past 52 weeks, while the S&P 500 index has surged 7.12 percent in the same period. Bristol-Myers Squibb shares climbed 0.83 percent to close at $65.96 yesterday.